Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of SEEOX and SOX Chemotherapeutic Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients

NCT02338518 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT02338518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02338518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of SEEOX and SOX Chemotherapeutic Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients
Lead sponsor
Jinling Hospital, China
Phase
Phase 3
Overall status
Unknown status
Start date
January 4, 2015
Completion date
October 31, 2023
Enrollment
297 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, stomach neoplasms